Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Current Assets (2023 - 2025)

Xenetic Biosciences' Current Assets history spans 6 years, with the latest figure at $8.0 million for Q4 2025.

  • For Q4 2025, Current Assets rose 22.2% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $8.0 million, up 22.2%, while the annual FY2025 figure was $8.0 million, 22.2% up from the prior year.
  • Current Assets reached $8.0 million in Q4 2025 per XBIO's latest filing, up from $5.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $12.9 million in Q1 2023 to a low of $5.1 million in Q3 2025.
  • Average Current Assets over 3 years is $8.3 million, with a median of $8.0 million recorded in 2024.
  • Peak YoY movement for Current Assets: crashed 37.57% in 2024, then rose 22.2% in 2025.
  • A 3-year view of Current Assets shows it stood at $9.6 million in 2023, then crashed by 31.29% to $6.6 million in 2024, then grew by 22.2% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Current Assets are $8.0 million (Q4 2025), $5.1 million (Q3 2025), and $5.4 million (Q2 2025).